Expression of S100B during heart failure in rats

( views:138, downloads:0 )
Author:
JIANG Zhen-ni(Deportment of Cardiology,The Second Affiliated Hospital of Zhejiang University Coltege of Medicine,Hangzhou 310009,China)
CHENG Ling(Deportment of Cardiology,The Second Affiliated Hospital of Zhejiang University Coltege of Medicine,Hangzhou 310009,China)
SHAN Jiang(Deportment of Cardiology,The Second Affiliated Hospital of Zhejiang University Coltege of Medicine,Hangzhou 310009,China)
WANG Jian-an(Deportment of Cardiology,The Second Affiliated Hospital of Zhejiang University Coltege of Medicine,Hangzhou 310009,China)
Journal Title:
CHINESE JOURNAL OF EMERGENCY MEDICINE
Issue:
Volume 17, Issue 05, 2008
DOI:
Key Word:
Ca2+-binding protein;S100B;Heart failure

Abstract: Objective To evaluate the value of S100B gene on cardiovascular remodeling in rats with abdominal aorta coarctation.Method Sprague-Dawley rats(sanitary degree,male),weighring(220~240)g,were used in the study.They were provided by College of Medicine,Zhejiang University.The abdominal aortas of rats were isolated and constricted so as to establish models of heart failure;the abdominal aortas of another ten rats were isolated but not ligated(sham-operation group).After one week,the 20 rats were alive and randomly divided into 2 groups:operation group(n=10)and Carvidilol-operation group(Car group,n=10).Car Group was treatedwith 2 mg·kg-1per day Carvedilol and operation group was administered with the same doses of normal saline.After 4 weeks,a catheter was inserted through the right jngular artery into the left ventricle to record hemodynamic.Then all rats were euthanized,and the heart tissues were rapidly excised,rinsed with PBS.The left ventricles were then cut into two parts at the equator:the upper sections were fixation,the lower sections were stoted at-80℃,at 100 mg per tube.LV transverse section(4μm thick)was subjected to S100B immunehistoc- hemistry.RNA was iselated from tissues by Trlzol to determine levels of S100BmRNA and β-actinmRNA by RT- PCR.The data was expressed as(x±s);One-way analysis of variance was used for comparison among groups, and Student-Newman-Keulsa test for comparison between two groups.Statistical significance was set at P<0.05. Results In Operation Group,there was a decrease in maximal rate of systolic and diastolic of left ventricular pressure(±dp/dtmax)[(1543.6±277.9)mmHg/s vs.(2640.4±481.3)mmHg/s and(-1352.5±202.3) mmHg/s vs.(-1873.2±412.3)mmHg/s];and an increase in left ventricular end diastolic pressure(LVEDP) [(24.8±5.2)mmHg vs.(2.1±0.7)mmHg]compared with sham-operation group(P<0.01,P<0.01 and P<0.05).And in Car group,the level of LVEDP was just in the midst of the Operation Group and sham-opera- tion group,and had statistical significance(P<0.01);while±dp/dtmac[(2372.3±92.6)mmHg/s and (-1786.4±62.6)mmHg/s]were much higher than those in operation group(P<0.01).There were no any S100B positive cells and expression of S100B mRNA in sham-operation group;while there were much more S100B positive cells in operation group than those in Car group(P<0.01).The expression of S100B mRNA in operation group was more pronounced than that in Car group.Changes in expression of S100BmRNA were positively correlat- ed with changes in LVEDP(r=0.847,P<0.01);while changes in expression of S100BmRNA were negatively correlated with changes in±dp/dt max(r=-0.853 and-0.689,beth P<0.01).Conclusions There was hish expression of S100B in myocytes from rats with experimental heart failure and negative correlation between the expression of S100B and heart function.It indicated that S100B could play a negative role in heart failure.

  • [1]Braunwald E,Bristow MR.Congestive heart failure:fifty years of progress[J].Circtdation,2000,102(20 Suppl 4):Ⅳ14-Ⅳ23.
  • [2]NacIntyre K,Capewell S,Stewart S,et al.Evidence of improving prognosis in heart failure:trends in case fatality in 66547 patients hospitalized between 1986 and 1995[J].Circulation,2000,102(10):1126-1131.
  • [3]Frank KF,Bolck B,Entmann E,et aL.Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation[J].Cardiovasc Res,2003,57(1):20-27.
  • [4]Houser SR,Piacentino V,Weisser J.Abnormalities of calcium cycling in the hypertrophied and failing heart[J].J Mol Cell Cardiol,2000,32(11):1595-1607.
  • [5]Plant DM,Yalani A,Ritsu H,et al.Calcium clynamics in the failing heart:resoration by beta-adrenergic receptor blockade[J].Am J Physiol,2003,285(1):H305-H315.
  • [6]尚游,袁世荧,姚尚龙.心搏骤停后脑损伤预后评价的新指标-血清S10013蛋白[J].中华急诊医学杂志,2004,13(5):357-358.
  • [7]Jonsson H,Johnsson P,Hoglund P,et al.Elimination of S100B and renal function after cantiae surgery[J].J Cardiothorac Vasc Anesth,2000,14(6):698-701.
  • [8]Anne B,Johann B,Wolfgang L,et al.Endothelial dysfunction coincides with an enhanced nitrix oxide synthase expression and superoxide anion production[J].Hypertension,1997,30(10):934-941.
  • [9]Tonnessen T,Christensen G,Oie E,et al.Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats[J].Cardiovascular Research,1997,33(3):601-610.
  • [10]Donalo R.S100:A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles[J].Int J Biochem Cell Biol,2001,33(7):637-668.
  • [11]Michetti F,Gazzolo D.S100B protein in biological fluids:a tool for perinatal medicine[J].Clin Chem,2002,48(12):2097-2104.
  • [12]Tsoporis JN,Marks Alexander,Haddad A,et al.S100B expressed modulates left ventricular remodeling after myocardial infarction in mice[J].Circulation,2005,111(5):598-606.
  • [13]Sorci G,Riuzz F,Agneletti AL,et al.S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner[J].Mol Cell Biol,2003,23(14):4870-4881.
  • [14]San F,Sawyer DB,Chang DLF,et al.Progressive remodeling and apoptosis late after myocardial infarction in mou8e heart[J].Am J Physiol,2000,279(1):H422-H428.
  • [15]Hsieh HL,Schafer BW,Weigle B,et al.S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation end products in human endothelial cells[J].Biochem Biophys Res Commun,2004,316(3):949-959.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn